Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Transfection
Authors:
Wienert B, Nguyen DN, Guenther A, Feng SJ, Locke MN, Wyman SK, Shin J, Kazane KR, Gregory GL, Carter MAM, Wright F, Conklin BR, Marson A, Richardson CD, Corn JE
In:
Nat Commun. (2020) 11(1): 2109
Categories:
Transfection
Authors:
Jiang W, Cazacu S, Xiang C, Zenklusen JC, Fine HA, Berens M, Armstrong B, Brodie C, Mikkelsen T
In:
Neoplasia (2008) 10(3): 235-43
Categories:
Transfection
Authors:
Kaul A, Overmeyer JH, Maltese WA
In:
Cell Signal (2007) 19(5): 1034-43
Categories:
Transfection
Authors:
Katayama M, Kawaguchi T, Berger MS, Pieper RO
In:
Cell Death Differ (2007) 14(3): 548-58
Categories:
Transfection
Authors:
Okhrimenko H, Lu W, Xiang C, Hamburger N, Kazimirsky G and Brodie C
In:
Cancer Res (2005) 65(16): 7301-7309